MORGAN STANLEY (MS) is a large-cap growth stock in the Investment Services industry. The rating using this strategy is 93% based on the firm’s underlying fundamentals and the stock’s valuation.

In the past 12 months, the stock has surged by nearly 58%. In the fourth quarter of 2024, Morgan Stanley (NYSE:MS) reported revenue of $16.2 billion, which showed a 25% growth from the same period ...

Biogen Inc.’s stock BIIB tumbled 7% Wednesday, after the biotech beat fourth-quarter earnings estimates but offered guidance that lagged behind consensus, as sales of its multiple sclerosis drug ...

Better-than-expected Alzheimer's disease treatment sales and a quarterly beat were not enough to offset below-consensus EPS outlook Biogen Inc.'s stock (BIIB) tumbled 7% Wednesday, after the ...

In this article, we are going to take a look at where Morgan Stanley (NYSE:MS) stands against the other large cap dividend growth stocks. Investors continue to favor large-cap stocks, as these ...

Next Monday, the stock market will be closed for President's Day. The major average will reopen on Tuesday. Workers at the US Department of Housing and Urban Development are bracing for deep ...

In this guide, you’ll find links to stores around the world that have either stock notifications, pre-orders, or actual stock available and we update it every day, to see if new stock has ...

UBS Maintains Buy on Trade Desk, Raises Price Target to $148 Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...